MMP-9 knockdown can reduce the migration and invasion of melanoma cells and inhibit epithelial-mesenchymal transformation (EMT), thus being considered as a promising molecule for the CM treatment (Tian et al., 2019). The gene discussed is MMP9; the disease is melanoma.